Methoxyphenamine
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Methoxyphenamine (trade names ASMI, Euspirol, Orthoxine, Ortodrinex, Proasma), also known as 2-methoxy–N–methylamphetamine (OMMA), is a β-adrenergic receptor agonist of the amphetamine class used as a bronchodilator.[1]
Chemistry
Methoxyphenamine was first synthesized at the Upjohn company by Woodruff and co-workers.[2] A later synthesis by Heinzelman, from the same company, corrects the m.p. given for methoxyphenamine hydrochloride in the earlier paper, and describes an improved synthetic procedure, as well as resolution of the racemic methoxyphenamine.[3]
References
- ↑ Swiss Pharmaceutical Society (2000). Index Nominum 2000: International Drug Directory (Book with CD-ROM). Boca Raton: Medpharm Scientific Publishers. ISBN 3-88763-075-0.
- ↑ E. H. Woodruff, J. P. Lambooy and W. E. Burt (1940). “Physiologically active amines. III. Secondary and tertiary β-phenylpropylamines and β-phenylisopropylamines.” J. Am. Chem. Soc. 62 922-924.
- ↑ R. V. Heinzelman (1953). “Physiologically active secondary amines. β-(o-Methoxyphenyl)-isopropyl-N-methylamine and related compounds.” J. Am. Chem. Soc. 75 921-925.
© 2026 MyEClinic – IFTM Institut für Telematik in der Medizin GmbH
